280 related articles for article (PubMed ID: 10210114)
1. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.
Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN
Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antitumor effects of a new boron compound combined with ultrasound on the mouse ascites tumor.
Ghosh P; Sur P; Bag SP
Med Chem; 2012 Nov; 8(6):1026-31. PubMed ID: 22779757
[TBL] [Abstract][Full Text] [Related]
3. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
Ghosh P; Bag SP; Sur B; Sur P
Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
[TBL] [Abstract][Full Text] [Related]
4. On the inhibitory activities of a new boron compound and ultrasound against the mouse ascites tumour.
Sur P; Ghosh P; Bag SP; Sur B; Chatterjee SN
Chemotherapy; 1999; 45(5):360-9. PubMed ID: 10473924
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces cerevisiae, the Baker's Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice.
Ghoneum M; Badr El-Din NK; Noaman E; Tolentino L
Cancer Immunol Immunother; 2008 Apr; 57(4):581-92. PubMed ID: 17891396
[TBL] [Abstract][Full Text] [Related]
6. [Dynamics of mitotic activity and frequency of pathologic mitoses in solid Ehrlich tumor after exposure to ultrasound and x-rays].
Smirnov RV; Pyshkina OV
Radiobiologiia; 1984; 24(5):662-6. PubMed ID: 6505159
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
[TBL] [Abstract][Full Text] [Related]
8. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
Bara A; Socaciu C; Silvestru C; Haiduc I
Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
[TBL] [Abstract][Full Text] [Related]
9. [Effect of weak combined static and low-frequency alternating magnetic fields on the Ehrlich ascites carcinoma in mice].
Novikov GV; Novikov VV; Fesenko EE
Biofizika; 2009; 54(6):1120-7. PubMed ID: 20067194
[TBL] [Abstract][Full Text] [Related]
10. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
11. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
Sur P; Bag SP; Sur B; Khanam JA
Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
[TBL] [Abstract][Full Text] [Related]
12. Boron substituted deoxyribonucleosides as cytotoxic agents.
Hall IH; Elkins A; Sood A; Tomasz J; SpielVogel BF
Anticancer Res; 1996; 16(6B):3709-14. PubMed ID: 9042245
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of abrin and ricin used singly and in combination with cisplatin.
Walker EM; Gale GR; Glassman AB; Atkins LM; Bennett CE; Burgis JT
Ann Clin Lab Sci; 1984; 14(1):10-20. PubMed ID: 6538076
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
15. A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice.
Ghosh P; Sur B; Bag SP; Sur P
Tumour Biol; 1999; 20(1):44-51. PubMed ID: 9858874
[TBL] [Abstract][Full Text] [Related]
16. In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3/Biobran on Ehrlich carcinoma-bearing mice.
Badr El-Din NK; Noaman E; Ghoneum M
Nutr Cancer; 2008; 60(2):235-44. PubMed ID: 18444156
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
Shenoy BD; Udupa N; Kamath R; Devi PU
Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
[TBL] [Abstract][Full Text] [Related]
19. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
Socaciu C; Bara A; Silvestru C; Haiduc I
In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
[TBL] [Abstract][Full Text] [Related]
20. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
